GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Covering GLP-1 drugs under company health plans brings significant financial implications. These medications come with a ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...

BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...

In the last couple of days at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting 2024, the ...

Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...